Breast cancer-specific expression of the Candida albicans cytosine deaminase gene using a transcriptional targeting approach

Cancer Gene Therapy

Volumn 7, Issue 6, 2000, Pages 845-852

  Anderson, Leonard M ^a   Krotz, Stephan ^a   Weitzman, Sigmund A ^a   Thimmapaya, Bayar ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Breast cancer; Cytosine deaminase; Gene therapy; Tissue specificity

Indexed keywords

CYTOSINE DEAMINASE; FLUCYTOSINE; FLUOROURACIL; FUNGAL ENZYME; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANDIDA ALBICANS; CELL STRAIN MCF 7; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SUICIDE GENE; SURVIVAL RATE; TRANSCRIPTION REGULATION;

ADENOVIRIDAE; ANIMALIA; CANDIDA ALBICANS; MINK CELL FOCUS-FORMING VIRUS; MUS MUSCULUS; OVIS;

EID: 0033946373     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700191     Document Type: Article

References (16)

1. Weichselbuam R, Kufe D. Gene therapy of cancer. Lancet. 1997;349;SII10-SII12.
2. Anderson LM, Swaminathan S, Zackon S, Tajuddin AK, Thimmapaya B, Weitzman SA. Adenovirus-mediated tissue targeted expression of the HSV-tk gene for the treatment of breast cancer. Gene Ther. 1999;6:854-864.
3. Anderson L, Kilstrup M, Neuhard J. Pyrimidine, purine, and nitrogen control of cytosine deaminase synthesis in Escherichia coli K12: involvement of the glnLG and purR genes in the regulation of codA expression. Arch Microbiol. 1989;152:115-118.
4. Mullen CA, Kilstrup M, Blaese RM. Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system. Proc Natl Acad Sci USA. 1992;89:33-37.
5. Kreuser ED, Wadler S, Thiel E. Biochemical modulation of cytotoxic drugs by cytokines: molecular mechanisms in experimental oncology. Recent Results Cancer Res. 1995; 139:371-382.
6. Topf N, Worgall S, Hacket NR, Crystal RG. Regional "pro-drug" gene therapy: intravenous administration of an adenoviral vector expressing the E. coli cytosine deaminase gene and systemic administration of 5-fluorocytosine suppresses growth of hepatic metastasis of colon carcinoma. Gene Ther. 1998;5:507-513.
7. Seymour C, Mothersill C. Cell communication and the "bystander effect." Radiat Res. 1999;151:505-506.
8. Jiang SY, Wolf DM, Yingling JM, Chang C, Jordan VC. An estrogen receptor MCF-7 clone that is resistant to antiestrogens and estradiol. Mol Cell Endocrinol. 1992;90: 77-86.
9. Murphy CS, Pink JJ, Jordan VC. Characterization of a receptor-negative, hormone-nonresponsive clone derived from a T47D human breast cancer cell line kept under estrogen-free conditions. Cancer Res. 1990;50:7285-7292.
10. Jiang SY, Jordan VC. Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor. J Natl Cancer Inst. 1992;90:77-91.
11. Swaminathan S, Thimmapaya B. Transactivation of adenovirus E2-early promoter by E1a and E4 6/7 in the context of the viral chromosome. J Mol Biol. 1996;258:736-746.
12. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248-254.
13. Reyniak JV. Endocrine physiology of the breast. J Reprod Med. 1979;22:303-309.
14. Collette J, Hendrick JC, Jasper JM, Franchimont P. Presence of α-lactalbumin, epidermal growth factor, epithelial membrane antigen, and gross cystic disease fluid protein (15,000) in breast cyst fluid. Cancer Res. 1986;46: 3728-3733.
15. Chen CY, Chang YN, Ryan P, Linscott M, McGarrity GJ, Chiang YL. Effect of herpes simplex virus thymidine kinase expression levels of ganciclovir-mediated cytotoxicity and the "bystander effect." Hum Gene Ther. 1995;6: 1467-1476.
16. Lawrence RS, Rehemtulla A, Ng EY, Wilson M, Trosko JE, Stetson PL. Preferential cytotoxicity of cells transduced with cytosine deaminase compared to bystander cells after treatment with 5-flurocytosine. Cancer Res. 1998;58:2588-2593.